Il molnupiravir riduce la durata dei sintomi ma non diminuisce i ricoveri o i decessi negli adulti v...
Il molnupiravir riduce la durata dei sintomi ma non diminuisce i ricoveri o i decessi negli adulti vaccinati con Covid-19
About this item
Full title
Author / Creator
Publisher
Rome: Pensiero Scientifico Editore
Journal title
Language
Italian
Formats
Publication information
Publisher
Rome: Pensiero Scientifico Editore
Subjects
More information
Scope and Contents
Contents
Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial. Efficacy of molnupiravir for the treatment of mild or moderate COVID-19 in adults: a meta-analysis. Peter K. Kurotschka1, Mark H. Ebell2, Al...
Alternative Titles
Full title
Il molnupiravir riduce la durata dei sintomi ma non diminuisce i ricoveri o i decessi negli adulti vaccinati con Covid-19
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_3174416025
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_3174416025
Other Identifiers
ISSN
0034-1193
E-ISSN
2038-1840
DOI
10.1701/4334.43180
